PURPOSE: Magnetic resonance imaging (MRI) provides superior visualization of the prostate and surrounding anatomy, making it the modality of choice for imaging the prostate gland. This pilot study was performed to determine the feasibility and dosimetric quality achieved when placing high-dose-rate prostate brachytherapy catheters under MRI guidance in a standard "closed-bore" 1.5T scanner. METHODS AND MATERIALS: Patients with intermediate-risk and high-risk localized prostate cancer received MRI-guided high-dose-rate brachytherapy boosts before and after a course of external beam radiotherapy. Using a custom visualization and targeting program, the brachytherapy catheters were placed and adjusted under MRI guidance until satisfactory implant geometry was achieved. Inverse treatment planning was performed using high-resolution T(2)-weighted MRI. RESULTS: Ten brachytherapy procedures were performed on 5 patients. The median percentage of volume receiving 100% of prescribed minimal peripheral dose (V(100)) achieved was 94% (mean, 92%; 95% confidence interval, 89-95%). The urethral V(125) ranged from 0% to 18% (median, 5%), and the rectal V(75) ranged from 0% to 3.1% (median, 0.3%). In all cases, lesions highly suspicious for malignancy could be visualized on the procedural MRI, and extracapsular disease was identified in 2 patients. CONCLUSION: High-dose-rate prostate brachytherapy in a standard 1.5T MRI scanner is feasible and achieves favorable dosimetry within a reasonable period with high-quality image guidance. Although the procedure was well tolerated in the acute setting, additional follow-up is required to determine the long-term safety and efficacy of this approach.
PURPOSE: Magnetic resonance imaging (MRI) provides superior visualization of the prostate and surrounding anatomy, making it the modality of choice for imaging the prostate gland. This pilot study was performed to determine the feasibility and dosimetric quality achieved when placing high-dose-rate prostate brachytherapy catheters under MRI guidance in a standard "closed-bore" 1.5T scanner. METHODS AND MATERIALS: Patients with intermediate-risk and high-risk localized prostate cancer received MRI-guided high-dose-rate brachytherapy boosts before and after a course of external beam radiotherapy. Using a custom visualization and targeting program, the brachytherapy catheters were placed and adjusted under MRI guidance until satisfactory implant geometry was achieved. Inverse treatment planning was performed using high-resolution T(2)-weighted MRI. RESULTS: Ten brachytherapy procedures were performed on 5 patients. The median percentage of volume receiving 100% of prescribed minimal peripheral dose (V(100)) achieved was 94% (mean, 92%; 95% confidence interval, 89-95%). The urethral V(125) ranged from 0% to 18% (median, 5%), and the rectal V(75) ranged from 0% to 3.1% (median, 0.3%). In all cases, lesions highly suspicious for malignancy could be visualized on the procedural MRI, and extracapsular disease was identified in 2 patients. CONCLUSION: High-dose-rate prostate brachytherapy in a standard 1.5T MRI scanner is feasible and achieves favorable dosimetry within a reasonable period with high-quality image guidance. Although the procedure was well tolerated in the acute setting, additional follow-up is required to determine the long-term safety and efficacy of this approach.
Authors: N Hata; M Jinzaki; D Kacher; R Cormak; D Gering; A Nabavi; S G Silverman; A V D'Amico; R Kikinis; F A Jolesz; C M Tempany Journal: Radiology Date: 2001-07 Impact factor: 11.105
Authors: A Pollack; G K Zagars; L G Smith; J J Lee; A C von Eschenbach; J A Antolak; G Starkschall; I Rosen Journal: J Clin Oncol Date: 2000-12-01 Impact factor: 44.544
Authors: A R Padhani; C J Gapinski; D A Macvicar; G J Parker; J Suckling; P B Revell; M O Leach; D P Dearnaley; J E Husband Journal: Clin Radiol Date: 2000-02 Impact factor: 2.350
Authors: N J Taylor; H Baddeley; K A Goodchild; M E Powell; M Thoumine; L A Culver; J J Stirling; M I Saunders; P J Hoskin; H Phillips; A R Padhani; J R Griffiths Journal: J Magn Reson Imaging Date: 2001-08 Impact factor: 4.813
Authors: Alvaro A Martinez; Gary Gustafson; José Gonzalez; Elwood Armour; Chris Mitchell; Gregory Edmundson; William Spencer; Jannifer Stromberg; Raywin Huang; Frank Vicini Journal: Int J Radiat Oncol Biol Phys Date: 2002-06-01 Impact factor: 7.038
Authors: Steven J DiBiase; Keya Hosseinzadeh; Rao P Gullapalli; Stephen C Jacobs; Michael J Naslund; Geoffrey N Sklar; Richard B Alexander; Cedric Yu Journal: Int J Radiat Oncol Biol Phys Date: 2002-02-01 Impact factor: 7.038
Authors: Georgina Fröhlich; Péter Agoston; József Lövey; András Somogyi; János Fodor; Csaba Polgár; Tibor Major Journal: Strahlenther Onkol Date: 2010-06-24 Impact factor: 3.621
Authors: Michael Muntener; Alexandru Patriciu; Doru Petrisor; Dumitru Mazilu; Herman Bagga; Louis Kavoussi; Kevin Cleary; Dan Stoianovici Journal: Urology Date: 2006-12 Impact factor: 2.649
Authors: Dan Stoianovici; Danny Song; Doru Petrisor; Daniel Ursu; Dumitru Mazilu; Michael Muntener; Michael Mutener; Michael Schar; Alexandru Patriciu Journal: Minim Invasive Ther Allied Technol Date: 2007 Impact factor: 2.442